ScholarIQanswers from OpenAlex

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer

PaperCitations, authors & open-access status

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer have?

ScholarIQcitation count

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer has 90 citations in the OpenAlex counts ScholarIQ stores.

When was TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer published?

ScholarIQyear

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer has 2018 year in the ScholarIQ index.

What is the open-access status of TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer?

ScholarIQoa status

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer has gold oa status in the ScholarIQ index.

What is the DOI of TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer?

ScholarIQdoi

The DOI for TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer is on the source record.

What is the PMID of TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer?

ScholarIQpmid

The PMID for TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer is on the source record.

What is the OpenAlex record for TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer?

ScholarIQopenalex

The OpenAlex for TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial